Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention of Delayed Post-polypectomy Bleeding by Endoscopic Sucralfate Spray in High-risk Patients
NCT07257926Phase 4Not yet recruiting
- Sponsor
- National Cheng Kung University Hospital
- Start
- Dec 2025
- Primary completion
- Dec 2027
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of sucralfate in postprocedural hemorrhage (2 arms), sponsored by National Cheng Kung University Hospital. Primary endpoint: Rate of delayed postpolypectomy bleeding at 28 days. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
sucralfate
03
Conditions
postprocedural hemorrhage
Beyond the preview
Go deeper on NCT07257926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07257926.